Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis

INTRODUCTION: Triple negative breast cancer (TNBC) has a poorer survival, despite a higher response rate to neoadjuvant chemotherapy. The purpose of this study was to identify the predictive or prognostic value of Ki-67 among patients with TNBC treated with neoadjuvant chemotherapy, and the role of...

Descripción completa

Detalles Bibliográficos
Autores principales: Keam, Bhumsuk, Im, Seock-Ah, Lee, Kyung-Hun, Han, Sae-Won, Oh, Do-Youn, Kim, Jee Hyun, Lee, Se-Hoon, Han, Wonshik, Kim, Dong-Wan, Kim, Tae-You, Park, In Ae, Noh, Dong-Young, Heo, Dae Seog, Bang, Yung-Jue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219180/
https://www.ncbi.nlm.nih.gov/pubmed/21366896
http://dx.doi.org/10.1186/bcr2834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219180/
https://www.ncbi.nlm.nih.gov/pubmed/21366896
http://dx.doi.org/10.1186/bcr2834

Ejemplares similares